Collectively, the favorable antiasthmatic action of MS might be interpreted and even mediated by reducing EOS infiltration, upregulating IL-10 expression, and downregulating IgE, IL-4, and IL-5 concentrations. The gene discussed is IL4; the disease is myeloid sarcoma.